Matches in Nanopublications for { ?s ?p "[Our study suggests that PHA- 767491 could enhance the efficacy of 5-FU by inhibiting Chk1 phosphorylation and down-regulating Mcl1 expression through inhibition of Cdc7 and Cdk9, thus combinational administration of PHA-767491 with 5-FU could be potentially beneficial to patients with advanced and resistant HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_assertion description "[Our study suggests that PHA- 767491 could enhance the efficacy of 5-FU by inhibiting Chk1 phosphorylation and down-regulating Mcl1 expression through inhibition of Cdc7 and Cdk9, thus combinational administration of PHA-767491 with 5-FU could be potentially beneficial to patients with advanced and resistant HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260205.RAYLAwZPCIeij-FjabDbLurOml0JItk6Uk2m1X3yZHF0w130_provenance.
- NP1260210.RAS0Tx9KWNYgBgPkt55JNLEToQIAz0HT9-tu3ej_DE_4Q130_assertion description "[Our study suggests that PHA- 767491 could enhance the efficacy of 5-FU by inhibiting Chk1 phosphorylation and down-regulating Mcl1 expression through inhibition of Cdc7 and Cdk9, thus combinational administration of PHA-767491 with 5-FU could be potentially beneficial to patients with advanced and resistant HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260210.RAS0Tx9KWNYgBgPkt55JNLEToQIAz0HT9-tu3ej_DE_4Q130_provenance.
- NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_assertion description "[Our study suggests that PHA- 767491 could enhance the efficacy of 5-FU by inhibiting Chk1 phosphorylation and down-regulating Mcl1 expression through inhibition of Cdc7 and Cdk9, thus combinational administration of PHA-767491 with 5-FU could be potentially beneficial to patients with advanced and resistant HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260206.RAByDVRjYLzr-zuO0jFlrkucTt_cYDs1U53bUN39Cwngw130_provenance.
- NP1260211.RA8CniisfoP_EyPs4R-wp3g1V8rvkN31mTuKPkOUJcdsg130_assertion description "[Our study suggests that PHA- 767491 could enhance the efficacy of 5-FU by inhibiting Chk1 phosphorylation and down-regulating Mcl1 expression through inhibition of Cdc7 and Cdk9, thus combinational administration of PHA-767491 with 5-FU could be potentially beneficial to patients with advanced and resistant HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1260211.RA8CniisfoP_EyPs4R-wp3g1V8rvkN31mTuKPkOUJcdsg130_provenance.